GlaxoSmithKline
GSK
#277
Rank
NZ$127.15 B
Marketcap
$62.32
Share price
0.23%
Change (1 day)
-2.79%
Change (1 year)

EPS for GlaxoSmithKline (GSK)

EPS in 2023 (TTM): $5.67

According to GlaxoSmithKline's latest financial reports the company's current EPS (TTM) is $6.20. In 2022 the company made an earnings per share (EPS) of $15.02 an increase over its 2021 EPS that were of $5.30.

EPS history for GlaxoSmithKline from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$5.67-62.24%
2022$15.02183.39%
2021$5.30-17.83%
2020$6.4521.82%
2019$5.3023.91%
2018$4.27141.48%
2017$1.7764.6%
2016$1.08-90.64%
2015$11.49178.14%
2014$4.13-48.16%
2013$7.9722.63%
2012$6.50-11.32%
2011$7.33230.25%
2010$2.22-70.98%
2009$7.646.76%
2008$7.16-15.14%
2007$8.447.82%
2006$7.8319.61%
2005$6.5418.56%
2004$5.520.36%
2003$5.5050.39%
2002$3.6631.13%
2001$2.79-25.43%
2000$3.7431.58%
1999$2.841.05%
1998$2.81-0.98%
1997$2.84-10.07%
1996$3.16

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$3.52-43.30%๐Ÿ‡ฌ๐Ÿ‡ง UK
$3.29-46.87%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.23-47.96%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.63 6.84%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$5.63-9.15%๐Ÿ‡ซ๐Ÿ‡ท France
-$3.54-157.13%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
$1.54-75.15%๐Ÿ‡บ๐Ÿ‡ธ USA